This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Aimm Therapeutics B.v., Kling Biotherapeutics B.v.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Christien Fatmawati: Innovator in Therapeutic Antibodies
Introduction
Christien Fatmawati is a notable inventor based in Amsterdam Zuidoost, Netherlands. He has made significant contributions to the field of biotherapeutics, particularly in the development of novel therapeutic antibodies. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Christien's latest patents include the "Therapeutic anti-CD9 antibody." This invention provides novel binding compounds and therapeutic applications thereof. His innovative approach in this area showcases his commitment to improving healthcare solutions.
Career Highlights
Throughout his career, Christien has worked with several prominent companies, including Kling Biotherapeutics B.V. and Aimm Therapeutics B.V. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in biotherapeutics.
Collaborations
Some of Christien's notable coworkers include Hergen Spits and Paula Maria Wilhelmina Van Helden. Their collaboration has likely fostered a creative environment that encourages innovation and the development of new therapeutic solutions.
Conclusion
Christien Fatmawati's work in the field of therapeutic antibodies exemplifies the impact of innovative thinking in medicine. His patents and collaborations highlight his dedication to advancing healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile